Why the study?
Does oral flecainide acetate reduce premature ventricular complexes in patients with chronic ventricular ectopy?
Population
13 patients with chronic ventricular ectopy
Comparison
Oral flecainide acetate vs Placebo control period (baseline)
Design
Cohort
Follow-up
2 weeks
Authors
Loading...
Supports short-term PVC suppression by flecainide in chronic ectopy; leaves open randomized confirmation of safety and efficacy.
Does oral flecainide acetate reduce premature ventricular complexes in patients with chronic ventricular ectopy?
Oral flecainide acetate is highly effective and well-tolerated for suppressing premature ventricular complexes in patients with chronic ventricular ectopy.
Anderson et al. (1981) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: